Featured Strategy

Mirae Asset

Focused on sectors or indices that are in a deep drawdown state, seeking mean-reversion opportunities.

Learn more
CategoryAlternative
No. of ETFs6 ETFs
Review CycleMonthly Review
Horizon5–7 Years

Performance

How this portfolio has performed

Compare growth against a benchmark across timelines and see what a hypothetical investment would be worth today.

In the period of
Amount (₹)00.3K0.5K0.8K1K1.3KOctDecFebAprJunAugTime

Overview

Understand this portfolio

Key metrics, suitability, and strategy highlights to help you evaluate whether this model portfolio fits your goals.

Investment Objective

Mean-reversion sector exposure

Target sectors in deep drawdown through a contrarian, mean-reversion ETF approach. Designed for patient investors who can tolerate extended periods of underperformance.

No. of ETFs

6 ETFs

Suggested Horizon

5–7 Years

Review Cycle

Monthly

Min. Investment

₹20,000

Who this may be suitable for

Investors with higher risk tolerance who believe deeply discounted sectors may recover over a longer horizon and can tolerate extended underperformance.

What investors should keep in mind

Contrarian strategies can remain out of favour for long stretches. Sector recovery timing is uncertain and losses may deepen before a turnaround.

  • Sector contrarian positioning
  • Deep drawdown opportunity focus
  • ETF-based sector exposure
  • Active review with disciplined rules

Holdings

Portfolio constituents and weights

Review the ETF mix and segment allocation that defines this model portfolio.

Log in to view holdings and allocation details

FAQs

Got questions? We've got answers!

Common questions about Mirae Asset Contra Fund and what to expect when you invest.

Mirae Asset Contra Fund is a contrarian sector ETF model portfolio focused on areas that have experienced deep drawdowns, seeking mean-reversion opportunities over a longer horizon.

Collateral

Documents and timelines

Download portfolio documents and review the scheduled rebalance checkpoints for this strategy.

Rebalance Timelines

  • Q1 Review — January 2026

    Quarterly allocation check against model targets and drift thresholds.

  • Q2 Review — April 2026

    Mid-year review of macro signals, risk metrics, and sleeve performance.

  • Q3 Review — July 2026

    Thematic and factor sleeve review with updated market regime assessment.

  • Q4 Review — October 2026

    Year-end reset to target weights and annual strategy documentation update.